Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Leucine/metformin

Next Previous
Drug Profile

Leucine/metformin

Alternative Names: L-leucine/metformin; Metformin/L-leucine; Metformin/leucine; NS-0100

Latest Information Update: 30 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator NuSirt Biopharma
  • Class Antihyperglycaemics; Biguanides; Branched-chain amino acids; Essential amino acids; Small molecules
  • Mechanism of Action AMP activated protein kinase stimulants; Gluconeogenesis inhibitors; Sirtuin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Type 2 diabetes mellitus

Most Recent Events

  • 23 Mar 2017 Phase-II development for Type-2 diabetes mellitus is ongoing in USA (PO)
  • 26 Jan 2016 NuSirt Biopharma completes a phase IIa trial in Type-2 diabetes mellitus in USA , (NCT02151461)
  • 25 Jun 2015 Pharmacodynamics data from preclinical studies in Type-2 diabetes mellitus released by NuSirt Biopharma

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top